Stryker Corporation (SYK)
NYSE: SYK
· Real-Time Price · USD
383.34
-5.45 (-1.40%)
At close: Sep 12, 2025, 3:59 PM
384.00
0.17%
After-hours: Sep 12, 2025, 07:41 PM EDT
Stryker Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedSurg Revenue | 3.77B | 3.51B | 4.18B | 3.22B | 3.12B | 3B | 3.43B | 2.86B | 2.86B | 2.69B | 3.05B | 2.59B | 2.55B | 2.42B | 4.41B | 1.75B | 1.75B | 1.62B | 1.85B | 1.6B | 1.32B | 1.62B | 1.84B | 1.58B | 1.62B | 1.54B | 1.72B | 1.44B | 1.46B | 1.43B | 1.58B | 1.34B | 1.34B | 1.3B | 1.43B | 1.25B | 1.26B | 958M | 1.09B | 943M | 939M | 927M | 1.05B | 936M | 905M | 886M | 924M | 792M | 819M | 824M | 877M | 781M | 786M | 821M | 2.39B | 766M |
| MedSurg Revenue Growth | +7.41% | -15.96% | +29.59% | +3.43% | +3.93% | -12.49% | +19.87% | -0.03% | +6.32% | -11.83% | +17.89% | +1.53% | +5.20% | -45.11% | +151.51% | +0.40% | +7.83% | -12.57% | +15.88% | +20.85% | -18.37% | -11.70% | +16.56% | -2.54% | +4.73% | -10.23% | +19.20% | -0.82% | +1.96% | -9.68% | +18.26% | 0.00% | +2.38% | -8.42% | +13.73% | -0.40% | +31.32% | -11.79% | +15.16% | +0.43% | +1.29% | -12.05% | +12.61% | +3.43% | +2.14% | -4.11% | +16.67% | -3.30% | -0.61% | -6.04% | +12.29% | -0.64% | -4.26% | -65.71% | +212.53% | n/a |
| Orthopaedics Revenue | 2.25B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.53B | 1.63B | 1.48B | 1.53B | 1.32B | 894M | 1.22B | 1.47B | 1.26B | 1.27B | 1.25B | 1.38B | 1.17B | 1.23B | 1.22B | 1.3B | 1.13B | 1.14B | 1.14B | 1.21B | 1.08B | 1.08B | 1.06B | 1.15B | 1.02B | 1.03B | 1.02B | 1.11B | 1.02B | 1.03B | 999M | 1.11B | 949M | 979M | 969M | 1.05B | 891M | 927M | 958M | 2.81B | 902M |
| Orthopaedics Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.08% | +9.70% | -2.75% | +15.87% | +47.32% | -26.84% | -16.70% | +16.24% | -0.86% | +1.84% | -9.16% | +17.51% | -4.64% | +0.99% | -6.82% | +15.28% | -0.79% | +0.53% | -5.89% | +11.98% | -0.46% | +2.37% | -7.77% | +12.46% | -1.55% | +1.17% | -7.84% | +9.25% | -1.17% | +2.90% | -9.76% | +16.65% | -3.06% | +1.03% | -7.45% | +17.51% | -3.88% | -3.24% | -65.88% | +211.31% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 1.47B | 1.43B | 1.39B | 1.38B | 1.33B | 1.23B | 1.28B | 1.27B | 1.12B | 1.18B | 1.17B | 1.14B | 1.19B | 1.17B | 989M | 798M | 945M | 943M | 955M | 937M | 861M | 937M | 927M | 958M | 824M | 812M | 791M |
| Non-Us Revenue Growth | +2.95% | +2.96% | +0.73% | +3.46% | +7.96% | -4.20% | +1.50% | +13.14% | -5.33% | +1.03% | +2.54% | -4.44% | +2.14% | +18.20% | +23.93% | -15.56% | +0.21% | -1.26% | +1.92% | +8.83% | -8.11% | +1.08% | -3.24% | +16.26% | +1.48% | +2.65% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.99B | 2.11B | 1.98B | 1.82B | 1.81B | 1.83B | 1.8B | 1.69B | 1.66B | 1.7B | 1.59B | 1.48B | 1.46B | 1.5B | 1.51B | 1.42B | 1.44B | 1.39B | 1.29B | 1.19B | 997M | 1.25B | 1.34B | 1.21B | 1.19B | 1.21B | 1.24B | 1.13B | 1.12B | 1.14B | 1.18B | 1.06B | 1.05B | 1.06B | 1.09B | 987M | 1.04B | 944M | 970M | 887M | 861M | 892M |
| Selling, General, and Administrative Revenue Growth | -5.46% | +6.25% | +8.95% | +0.39% | -1.14% | +1.89% | +6.32% | +2.36% | -2.70% | +6.78% | +7.35% | +1.85% | -2.93% | -0.40% | +6.20% | -1.18% | +3.31% | +7.50% | +9.02% | +18.96% | -19.92% | -6.81% | +10.05% | +1.85% | -1.65% | -2.26% | +9.83% | +0.71% | -1.23% | -3.57% | +11.14% | +0.57% | -0.57% | -3.11% | +10.74% | -5.37% | +10.49% | -2.68% | +9.36% | +3.02% | -3.48% | n/a |
| Research and Development Revenue | 396M | 393M | 342M | 364M | 352M | 356M | 328M | 335M | 319M | 311M | 284M | 317M | 323M | 306M | 331M | 306M | 310M | 288M | 255M | 242M | 233M | 254M | 254M | 246M | 246M | 225M | 221M | 221M | 216M | 204M | 205M | 198M | 192M | 192M | 189M | 184M | 183M | 159M | 164M | 155M | 154M | 152M |
| Research and Development Revenue Growth | +0.76% | +14.91% | -6.04% | +3.41% | -1.12% | +8.54% | -2.09% | +5.02% | +2.57% | +9.51% | -10.41% | -1.86% | +5.56% | -7.55% | +8.17% | -1.29% | +7.64% | +12.94% | +5.37% | +3.86% | -8.27% | 0.00% | +3.25% | 0.00% | +9.33% | +1.81% | 0.00% | +2.31% | +5.88% | -0.49% | +3.54% | +3.12% | 0.00% | +1.59% | +2.72% | +0.55% | +15.09% | -3.05% | +5.81% | +0.65% | +1.32% | n/a |